Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3QJW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,206
Award facts
- Contract value 100% obligated
- $7,206.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 mL pen injectors with a ceiling value of $7,206.04. This non-competitive, firm fixed price delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe atopic dermatitis, asthma, and other inflammatory conditions, making this a specialized pharmaceutical supply for military healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has been competitively selected to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this flexible contracting arrangement.
Quick answers
Who was awarded contract SPE2DR26F3QJW?
SPE2DR26F3QJW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F3QJW worth?
The government has obligated $7,206 on SPE2DR26F3QJW.
Is contract SPE2DR26F3QJW an order under another contract?
Yes. SPE2DR26F3QJW is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QJW competed?
The extent of competition for SPE2DR26F3QJW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award